Evidence map›Paper›PMID 40154617›Full record

ReviewThe Journal of biological chemistry2025

Flavin transferase ApbE: From discovery to applications.

Xiaoman Fan, Marco W Fraaije

Abstract readReview
In one paragraph

Review in The Journal of biological chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Xiaoman FanMolecular Enzymology, University of Groningen, Groningen, The Netherlands.
Marco W FraaijeMolecular Enzymology, University of Groningen, Groningen, The Netherlands. Electronic address: m.w.fraaije@rug.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ApbE is a unique, membrane-bound enzyme which covalently attaches a flavin cofactor to specific target proteins. This irreversible posttranslational modification is crucial for proper functioning of various bacterial proteins. ApbEs have also been identified in archaea and eukaryotes. This review summarizes current knowledge on the structural and mechanistic properties of this unique protein-modifying enzyme and its recent applications. The flavin transferase is typically membrane-anchored and located in the periplasm and it possesses a conserved flavin-binding domain and a catalytic domain. It recognizes a specific sequence motif of target proteins, resulting in flavinylation of a threonine or serine. For flavinylation, it depends on magnesium and utilizes flavin adenine dinucleotide as substrate to attach the flavin mononucleotide moiety to the target protein, analogous to phosphorylation. ApbE-mediated flavinylation supports critical bacterial respiratory and metabolic pathways. Recently, ApbE was also shown to be a versatile tool for selectively modifying proteins. Using the flavin-tagging approach, proteins can be decorated with flavin mononucleotide or other flavins. Furthermore, it was demonstrated that ApbE can be employed to turn natural noncovalent flavoproteins into covalent flavoproteins. In summary, ApbE is crucial for the maturation of various flavoproteins by catalyzing covalent flavinylation. While great progress has been made in understanding the role and mode of action of ApbE, there are still many bacterial proteins predicted to be flavinylated by ApbE for which their role is enigmatic. Also, exploration of the potential of ApbE as protein modification tool has just begun. Clearly, future research will generate new ApbE-related insights and applications.

Indexed as

Bacterial ProteinsFlavinsProtein Processing, Post-TranslationalTransferasesFlavin-Adenine DinucleotideFlavoproteinsHumansBacterial ProteinsFlavin-Adenine DinucleotideFlavinsFlavoproteinsTransferasescovalent flavinylationflavin transferaseFMNposttranslational modification

Identifiers

PMID40154617
PMCPMC12052999

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.